Table 4.
Effect of RP on Pharmacare NSAID Expenditures
| NSAIDs | ||||
|---|---|---|---|---|
| Estimate | p-Value | 95% CI | ||
| Effect of Type 1 RP | ||||
| Cumulative effect over all months | −$7,506,214 | <.001 | −$10,900,000 | −$4,098,872 |
| Cumulative effect per year | −$1,035,340 | <.001 | −$1,505,318 | −$565,362 |
| Effect of Type 2 RP | ||||
| Cumulative effect over all months | −$22,700,000 | <.001 | −$24,800,000 | −$20,600,000 |
| Cumulative effect per year | −$4,007,322 | <.001 | −$4,378,332 | −$3,636,312 |